Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Comparison of protein expression profiles between bortezomib-resistant JurkatB cells with PSMB5 mutation and their parent cells].

Zhongguo shi yan xue ye xue za zhi - 1 Aug 2011

Lü Shu-Qing, Yang Jian-Min, Huang Chong-Mei, Xu Xiao-Qian, Zhou Hong, Song Ning-Xia, Wang Jian-Min

Abstract excerpt

This study was purposed to investigate the differences of cyto biological characteristics and protein expression levels between bortezomib-resistant T-lymphoblastic lymphoma/leukemia cell lines JurkatB containing PSMB5 G322A mutation and their parent cell line Jurkat, The cytotoxicities of bortezomib and chemotherapeutic drugs to JurkatB5 cells (end selection concentration of bortezomib was 500 nmol/L), JurkatB8...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Boronic Acids
Share to Bortezomib

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Cell Line, Tumor

Share to Drug Resistance, Multiple

Share to Gene Expression Profiling

Share to Jurkat Cells

Share to Proteasome Endopeptidase Complex

Share to Pyrazines

Source

Identifiers

PMID: 21867604

Genes

PSMB5

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Comparison of protein expression profiles between bortezomib-resistant JurkatB cells with PSMB5 mutation and their parent cells].PMID 21867604Read ↗

Different mutants of PSMB5 confer varying bortezomib resistance in T lymphoblastic lymphoma/leukemia cells derived from the Jurkat cell line.Semantic proximity Read ↗

Identification of proteins responsible for the multiple drug resistance in 5-fluorouracil-induced breast cancer cell using proteomics analysisSemantic proximity Read ↗

Bortezomib-resistant myeloma cell lines: a role for mutated PSMB5 in preventing the accumulation of unfolded proteins and fatal ER stress.Semantic proximity Read ↗

Gene expression analysis of B‐lymphoma cells resistant and sensitive to bortezomib*Semantic proximity Read ↗

Investigating the mechanisms underlying Bortezomib resistanceSemantic proximity Read ↗

Molecular basis of bortezomib resistance: proteasome subunit beta5 (PSMB5) gene mutation and overexpression of PSMB5 protein.Semantic proximity Read ↗

Impaired bortezomib binding to mutant β5 subunit of the proteasome is the underlying basis for bortezomib resistance in leukemia cells.Semantic proximity Read ↗

Clinically relevant pulse-treatment generates bortezomib-resistant myeloma cell line that lacks proteasome mutations and is sensitive to Bcl-2 inhibitor venetoclaxSemantic proximity Read ↗

Mutations in beta-tubulin map to domains involved in regulation of microtubule stability in epothilone-resistant cell lines.Semantic proximity Read ↗

Molecular Mechanisms of Bortezomib Resistant Adenocarcinoma CellsSemantic proximity Read ↗

Autophagy and oxidative stress modulation mediate Bortezomib resistance in prostate cancerSemantic proximity Read ↗

Inactivating PSMB5 mutations and P-glycoprotein (multidrug resistance-associated protein/ATP-binding cassette B1) mediate resistance to proteasome inhibitors: ex vivo efficacy of (immuno)proteasome inhibitors in mononuclear blood cells from patients with rheumatoid arthritis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.